Phreesia/$PHR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Phreesia
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Ticker
$PHR
Sector
Primary listing
NYSE
Employees
2,082
Headquarters
Website
Phreesia Metrics
BasicAdvanced
$1.4B
-
-$0.42
0.68
-
Price and volume
Market cap
$1.4B
Beta
0.68
52-week high
$32.76
52-week low
$17.07
Average daily volume
842K
Financial strength
Current ratio
2.118
Quick ratio
1.666
Long term debt to equity
1.596
Total debt to equity
4.293
Interest coverage (TTM)
-10.56%
Profitability
EBITDA (TTM)
-4.765
Gross margin (TTM)
68.02%
Net profit margin (TTM)
-5.35%
Operating margin (TTM)
-4.73%
Effective tax rate (TTM)
-4.22%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
-3.45%
Return on equity (TTM)
-8.76%
Valuation
Price to revenue (TTM)
3.016
Price to book
4.64
Price to tangible book (TTM)
9.74
Price to free cash flow (TTM)
48.616
Free cash flow yield (TTM)
2.06%
Free cash flow per share (TTM)
0.475
Growth
Revenue change (TTM)
15.31%
Earnings per share change (TTM)
-76.65%
3-year revenue growth (CAGR)
22.41%
3-year earnings per share growth (CAGR)
-50.79%
What the Analysts think about Phreesia
Analyst ratings (Buy, Hold, Sell) for Phreesia stock.
Bulls say / Bears say
Phreesia posted its first-ever GAAP net income-positive quarter in Q2 FY2026, reporting net income of $0.7 million versus a net loss of $18.0 million a year ago, demonstrating clear progress toward profitability (Business Wire)
Revenue was up 15% year-over-year at $117.3 million in Q2 FY2026, with strong double-digit growth across subscription services, network solutions, and payment processing fees (Business Wire)
The $160 million all-cash purchase of AccessOne is expected to add around $35 million in annualized revenue and $11 million in Adjusted EBITDA, broadening Phreesia’s addressable market for payment solutions by roughly $6 billion (HLTH.com)
Sequential client growth slowed in Q2, with Phreesia adding only 56 net new healthcare services clients compared to 70 in the previous quarter, suggesting potential market saturation in its core area (Nasdaq)
Management kept full-year 2026 revenue guidance unchanged at $472 million–$482 million despite a strong Q2, signaling that they don't expect significant short-term upside to revenue forecasts (Nasdaq)
Phreesia shares declined 8.8% after announcing Q2 earnings and the AccessOne acquisition, pointing to investor worries about the debt-financed deal and possible distraction from its main business (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.
Phreesia Financial Performance
Revenues and expenses
Phreesia Earnings Performance
Company profitability
Phreesia News
AllArticlesVideos
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling
Business Wire2 weeks ago
Phreesia Named to TIME's 2025 List of the World's Top HealthTech Companies
Business Wire3 weeks ago
Becker's Names Phreesia's Sara DiNardo as one of 2025's Rising Stars of Healthcare
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Phreesia stock?
Phreesia (PHR) has a market cap of $1.4B as of October 22, 2025.
What is the P/E ratio for Phreesia stock?
The price to earnings (P/E) ratio for Phreesia (PHR) stock is 0 as of October 22, 2025.
Does Phreesia stock pay dividends?
No, Phreesia (PHR) stock does not pay dividends to its shareholders as of October 22, 2025.
When is the next Phreesia dividend payment date?
Phreesia (PHR) stock does not pay dividends to its shareholders.
What is the beta indicator for Phreesia?
Phreesia (PHR) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.